Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer

Abstract

Results of the proton magnetic resonance spectroscopy carried out on normal, benign breast disease and locally advanced breast cancer patients are presented. The in-vivo MR spectra of malignant breast tissue of patients (n = 67) suffering from infiltrating ductal carcinoma are dominated by the water resonance, while the spectra of the unaffected contralateral breast tissue of these patients are mainly dominated by resonance arising from lipids which is similar to the spectra of normal breast tissue obtained from volunteers (controls, n = 16). In addition to the water and lipid peaks, in majority of the patients (approximately 80%) the water suppressed spectra showed a resonance at 3.2 ppm due to choline containing compounds (TCho) before treatment. In patients receiving neoadjuvant chemotherapy, absence/reduction in choline was observed in 89% of the patients. TCho was also observed in 2 of 14 benign lesions. The sensitivity and specificity of in-vivo MRS in detecting TCho in malignant tumours was 78% and 86%, respectively. Observation of TCho before treatment and its disappearance (or reduction) after treatment may be a useful indicator of response of locally advanced breast cancer to neoadjuvant chemotherapy.

References 26

1. 1.

   Boné B., Péntek Z., Perbeck L., Veress B. Diagnostic accuracy of mammography and contrast-enhanced MR imaging in 238 histologically verified breast lesions. Acta Radiol. 1997;38(4 Pt 1):489-496.

   Not in our library10.1080/02841859709174374

2. 2.

   Daniel B. L., Yen Y. F., Glover G. H., Ikeda D. M., Birdwell R. L., Sawyer-Glover A. M., Black J. W., Plevritis S. K., Jeffrey S. S., Herfkens R. J. Breast disease: dynamic spiral MR imaging. Radiology. 1998;209(2):499-509.

   Not in our library10.1148/radiology.209.2.9807580

3. 3.

   Friedrich M. MRI of the breast: state of the art. Eur Radiol. 1998;8(5):707-725.

   Not in our library10.1007/s003300050463

4. 4.

   Glaholm J., Leach M. O., Collins D. J., Mansi J., Sharp J. C., Madden A., Smith I. E., McCready V. R. In-vivo 31P magnetic resonance spectroscopy for monitoring treatment response in breast cancer. Lancet. 1989;1(8650):1326-1327.

   Not in our library10.1016/s0140-6736(89)92717-7

5. 5.

   Goel A. K., Seenu V., Shukla N. K., Raina V. Breast cancer presentation at a regional cancer centre. Natl Med J India. 1995;8(1):6-9.

   Not in our library

6. 6.

   Gribbestad I. S., Fjösne H. E., Haugen O. A., Nilsen G., Krane J., Petersen S. B., Kvinnsland S. In vitro proton NMR spectroscopy of extracts from human breast tumours and non-involved breast tissue. Anticancer Res. 1993;13(6A):1973-1980.

   Not in our library

7. 7.

   Gribbestad I. S., Singstad T. E., Nilsen G., Fjøsne H. E., Engan T., Haugen O. A., Rinck P. A. In vivo 1H MRS of normal breast and breast tumors using a dedicated double breast coil. J Magn Reson Imaging. 1998;8(6):1191-1197.

   Not in our library10.1002/jmri.1880080602

8. 8.

   Harms S. E., Flamig D. P., Hesley K. L., Meiches M. D., Jensen R. A., Evans W. P., Savino D. A., Wells R. V. MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology. 1993;187(2):493-501.

   Not in our library10.1148/radiology.187.2.8475297

9. 9.

   Heywang-Köbrunner S. H., Viehweg P., Heinig A., Küchler C. Contrast-enhanced MRI of the breast: accuracy, value, controversies, solutions. Eur J Radiol. 1997;24(2):94-108.

   Not in our library10.1016/s0720-048x(96)01142-4

10. 10.

    Jagannathan N. R., Singh M., Govindaraju V., Raghunathan P., Coshic O., Julka P. K., Rath G. K. Volume localized in vivo proton MR spectroscopy of breast carcinoma: variation of water-fat ratio in patients receiving chemotherapy. NMR Biomed. 1998;11(8):414-422.

    Not in our library10.1002/(sici)1099-1492(199812)11:8<414::aid-nbm537>3.0.co;2-w

11. 11.

    Kaiser W. A. MR-Mammographie. Radiologe. 1993;33(5):292-299.

    Not in our library

12. 12.

    Kasimos J. N., Merchant T. E., Gierke L. W., Glonek T. 31P magnetic resonance spectroscopy of human colon cancer. Cancer Res. 1990;50(3):527-532.

    Not in our library

13. 13.

    Katz-Brull R., Margalit R., Bendel P., Degani H. Choline metabolism in breast cancer; 2H-, 13C- and 31P-NMR studies of cells and tumors. MAGMA. 1998;6(1):44-52.

    Not in our library10.1007/bf02662511

14. 14.

    Kvistad K. A., Bakken I. J., Gribbestad I. S., Ehrnholm B., Lundgren S., Fjøsne H. E., Haraldseth O. Characterization of neoplastic and normal human breast tissues with in vivo (1)H MR spectroscopy. J Magn Reson Imaging. 1999;10(2):159-164.

    Not in our library10.1002/(sici)1522-2586(199908)10:2<159::aid-jmri8>3.0.co;2-0

15. 15.

    Leach M. O., Verrill M., Glaholm J., Smith T. A., Collins D. J., Payne G. S., Sharp J. C., Ronen S. M., McCready V. R., Powles T. J. Measurements of human breast cancer using magnetic resonance spectroscopy: a review of clinical measurements and a report of localized 31P measurements of response to treatment. NMR Biomed. 1998;11(7):314-340.

    Not in our library10.1002/(sici)1099-1492(1998110)11:7<314::aid-nbm522>3.0.co;2-z

16. 16.

    Mackinnon W. B., Barry P. A., Malycha P. L., Gillett D. J., Russell P., Lean C. L., Doran S. T., Barraclough B. H., Bilous M., Mountford C. E. Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy. Radiology. 1997;204(3):661-666.

    Not in our library10.1148/radiology.204.3.9280241

17. 17.

    Merchant T. E., Gierke L. W., Meneses P., Glonek T. 31P magnetic resonance spectroscopic profiles of neoplastic human breast tissues. Cancer Res. 1988;48(18):5112-5118.

    Not in our library

18. 18.

    Orel S. G. High-resolution MR imaging for the detection, diagnosis, and staging of breast cancer. Radiographics. 1998;18(4):903-912.

    Not in our library10.1148/radiographics.18.4.9672975

19. 19.

    Orel S. G., Hochman M. G., Schnall M. D., Reynolds C., Sullivan D. C. High-resolution MR imaging of the breast: clinical context. Radiographics. 1996;16(6):1385-1401.

    Not in our library10.1148/radiographics.16.6.8946543

20. 20.

    Piccoli C. W. Contrast-enhanced breast MRI: factors affecting sensitivity and specificity. Eur Radiol. 1997;7(Suppl 5):281-288.

    Not in our library10.1007/pl00006909

21. 21.

    Roebuck J. R., Cecil K. M., Schnall M. D., Lenkinski R. E. Human breast lesions: characterization with proton MR spectroscopy. Radiology. 1998;209(1):269-275.

    Not in our library10.1148/radiology.209.1.9769842

22. 22.

    Sijens P. E., Wijrdeman H. K., Moerland M. A., Bakker C. J., Vermeulen J. W., Luyten P. R. Human breast cancer in vivo: H-1 and P-31 MR spectroscopy at 1.5 T. Radiology. 1988;169(3):615-620.

    Not in our library10.1148/radiology.169.3.2847230

23. 23.

    Singer S., Souza K., Thilly W. G. Pyruvate utilization, phosphocholine and adenosine triphosphate (ATP) are markers of human breast tumor progression: a 31P- and 13C-nuclear magnetic resonance (NMR) spectroscopy study. Cancer Res. 1995;55(22):5140-5145.

    Not in our library

24. 24.

    Smith T. A., Eccles S., Ormerod M. G., Tombs A. J., Titley J. C., Leach M. O. The phosphocholine and glycerophosphocholine content of an oestrogen-sensitive rat mammary tumour correlates strongly with growth rate. Br J Cancer. 1991;64(5):821-826.

    Not in our library10.1038/bjc.1991.407

25. 25.

    Twelves C. J., Porter D. A., Lowry M., Dobbs N. A., Graves P. E., Smith M. A., Rubens R. D., Richards M. A. Phosphorus-31 metabolism of post-menopausal breast cancer studied in vivo by magnetic resonance spectroscopy. Br J Cancer. 1994;69(6):1151-1156.

    Not in our library10.1038/bjc.1994.226

26. 26.

    den Hollander J. A., Luyten P. R., Mariën A. J., Segebarth C. M., Balériaux D. F., de Beer R., van Ormondt D. Potentials of quantitative image-localized human 31P nuclear magnetic resonance spectroscopy in the clinical evaluation of intracranial tumors. Magn Reson Q. 1989;5(2):152-168.

    Not in our library

Cited by papers we hold 5

• Phosphatidylcholine-Derived Lipid Mediators: The Crosstalk Between Cancer Cells and Immune Cells · 2022
  No notice
• Imaging biomarkers for evaluating tumor response: RECIST and beyond · 2021
  No notice
• Current State of Breast Cancer Diagnosis, Treatment, and Theranostics · 2021
  No notice
• Targeting Phospholipid Metabolism in Cancer · 2016
  No notice
• Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy · 2006
  Corrected

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.